ArticleCancers2025

A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo.

Dimitrios Filioglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.